Stockwinners Market Radar for November 25, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

13:11 EST Philip Morris announces new regional structure, management changes - Philip Morris announced a new regional structure and related senior management changes. By the end of January 2023, PMI will rearrange its operations in four regions, down from the current six, under the leadership of the following members of senior management: Paul Riley, currently president, East Asia & Australia Region, will be appointed president, East Asia, Australia, and PMI Duty Free Region; Frederic de Wilde, currently president, European Union Region, will be appointed president, South and Southeast Asia, Commonwealth of Independent States, Middle East and Africa Region; Massimo Andolina, currently senior VP, operations, will be appointed president, Europe Region and Deepak Mishra, who will continue as president, Americas Region. Drago Azinovic, currently president, Middle East and Africa and PMI Duty Free Region, will leave the organization after a transition period. In addition, the following appointments will also take effect: Marco Mariotti, currently president, Eastern Europe Region, will be appointed president, CIS, Central Asia & Israel, reporting into Frederic de Wilde; Stacey Kennedy, currently president, South and Southeast Asia Region, will be appointed CEO of PMI's U.S. business, reporting to Deepak Mishra and Scott Coutts, currently VP, Global Manufacturing, will be appointed senior VP, operations, succeeding Massimo Andolina and reporting into Jacek Olczak. Each region will comprise individual markets, as well as clusters of markets. The company's quarterly results' reporting and related filings will reflect the new regional structure as of Q1 2023.

12:05 EST Alpine 4 Holdings receives additional noncompliance notification from Nasdaq - Alpine 4 Holdings announced that it received an additional staff determination notice from the Listing Qualifications Department of Nasdaq Stock Market advising that Nasdaq had not received Alpine 4's Form 10-Q for the quarterly period ended September 30 and that as such, Alpine 4 was not in compliance with Nasdaq Listing Rule 5250. Alpine 4 has 60 calendar days from November 21, to submit to Nasdaq a plan outlining Alpine 4's anticipated steps to regain compliance with the listing rule. Alpine 4 plans to submit the plan explaining the strategy to make the required SEC filings, and to regain compliance with the listing rule.

12:00 EST Super Group falls -10.8% - Super Group is down -10.8%, or -39c to $3.23.

12:00 EST HireRight rises 10.4% - HireRight is up 10.4%, or $1.12 to $11.90.

12:00 EST Ampco-Pittsburgh rises 18.2% - Ampco-Pittsburgh is up 18.2%, or 53c to $3.44.

11:21 EST Qiwi chairman offers to purchase 5M shares for $2.00 per share - Qiwi announced that on November 25, Dalliance Services has launched an offer to purchase for cash up to 5M of company's Class B ordinary shares at a purchase price of $2.00. According to the offer document, the offer was filed by Dalliance Services and Sergey Solonin, the controlling shareholder and chairman of the board of directors of Qiwi. The offer document highlights that the offeror is wholly owned by Solonin. As per the offer documentation the purpose of the offer is to provide further liquidity to the company's stockholders who did not tender their shares or shares represented by ADSs in the previous offer and remain limited in their ability to extract value from their holdings because they are unable to trade the shares or shares represented by ADSs because of the Trading Halt or the MOEX Restrictions or receive dividends because of the sanctions imposed on the Russian National Settlement Depositary. As indicated in the offer documentation, the offer is made with respect to up to 5M of Class B ordinary shares or shares represented by American Depositary Shares, at the purchase price of $2.00 per share in cash, less any applicable withholding taxes and without interest. It is also stated in the offer, if the offer is fully subscribed and the offeror may elect to exercise an option to increase the number of shares accepted for payment in the offer by no more than 2% of the outstanding shares without extending the expiration time, in which case the Offeror may purchase up to 6,045,989 Shares. The Offer is not subject to any financing condition but is subject to a number of other conditions outlined in the offer document. According to the offer document, the Offer and withdrawal rights will expire at 12:00 midnight, New York City time, at the end of the day on December 22, 2022, unless the Offer is extended, which the Offeror may elect to do in its sole discretion. The Offeror indicated that it does not currently anticipate that there will be a subsequent offering period. The Company and its Board of Directors have not expressed any position on the Offer. We will make appropriate disclosures with respect to the Offer after due and careful consideration, including a thorough review of the terms and conditions of the revised Offer. QIWI is not selling or buying any shares in the offering and will not spend or receive any funds from the offering.

10:00 EST Energy Vault falls -9.0% - Energy Vault is down -9.0%, or -44c to $4.45.

10:00 EST HireRight rises 7.3% - HireRight is up 7.3%, or 79c to $11.57.

10:00 EST Manchester United rises 9.9% - Manchester United is up 9.9%, or $1.86 to $20.66.

09:47 EST Grindr falls -6.5% - Grindr is down -6.5%, or -65c to $9.35.

09:47 EST HireRight rises 5.0% - HireRight is up 5.0%, or 54c to $11.32.

09:47 EST Manchester United rises 8.6% - Manchester United is up 8.6%, or $1.62 to $20.42.

09:40 EST IDBA Stock trading resumes

09:34 EST ACRV Stock trading halted, volatility trading pause

09:30 EST IDBA Stock trading halted, volatility trading pause

09:02 EST BMW to invest more than 2B euros in Hungarian plant as part of 'e-mobility' plan - The BMW Group is building a high-voltage battery assembly for the vehicles of the NEUE KLASSE at its site in Hungary, the company announced. "The battery assembly will be located on the site of the Debrecen vehicle plant, which started construction about six months ago. The company will create more than 500 additional jobs and invest over two billion euros in the construction and launch of the entire plant by the end of 2025," said BMW. Milan Nedeljkovi, member of the Board of Management of BMW AG, Production, said: "In Debrecen, we are building the most advanced plant in the world. With our iFACTORY, we are setting new industry standards for vehicle production. Our investments underline our systematic approach to implementing e-mobility." Reference Link

08:33 EST Medigus says Charging Robotics to release beta version of user interface - Medigus announced that its wholly owned subsidiary, Charging Robotics Ltd., is anticipated to release a beta version of the user interface application for the wireless charging robot of Charging Robotics by the end of the year. The beta version of the user interface will be released as part of collaboration between Charging Robotics and Make My Day, a company that develops apps and services for EV fleet management and optimization of charging and battery usage. Using the app developed by Make My Day, customers of Charging Robotics will be able to order the charging service offered by the robots, receive information about billing, receive driving instructions to the destination as well as receive real time data about the EV electricity consumption and battery state of charge. The first product Charging Robotics will release will be a robot to automatically charge electric vehicles for disabled drivers. These drivers have an extreme difficulty to charge electric vehicles because the process of taking the cable from the charger and plugging it to the EV is very challenging for individuals using wheelchairs or suffering from other conditions impairing their mobility. With the dedicated Charging Robotics system, and by a tap in the app developed by Make My Day, the robot will automatically charge the vehicle. This development will allow disabled drivers to effortlessly charge their vehicles and will significantly reduce the access areas around the charger required by currently available cable-based chargers. The system for charging EV of handicapped drivers is planned to start pilot tests during Q1 of 2023.

08:31 EST Great Panther Mining terminates Share Purchase Agreement with Newrange Gold - Great Panther Mining announces that it has terminated the Share Purchase Agreement previously reached with Newrange Gold to sell to Newrange the company's Peruvian subsidiaries, which together indirectly own the Coricancha Mine in Peru, Great Panther Peru Holdings Ltd. and Great Panther Silver Peru S.A.C. Completion of the Agreement was subject to certain closing conditions including, but not limited to, the approval of the TSX Venture Exchange as well as evidence of sufficient financing to support the transaction. Coricancha, located in the central Andes of Peru approximately 90 kilometres east of Lima is a past producing mine which the company acquired in June 2017 and has remained in care and maintenance since then.

08:27 EST Veris Residential says Kushner $16 per share bid 'grossly undervalues' company - In a regulatory filing, Veris Residential disclosed that on November 25, the board of directors the company responded in writing to the Kushner Companies regarding its proposal to acquire the company for $16.00 per share. "The Board unanimously believes that the Kushner Companies' $16.00 per share proposal grossly undervalues the company and denies shareholders the substantial, long-term value expected to be unlocked from the company's nearly complete strategic transformation. The Board remains open to evaluating any proposals to maximize value for all shareholders," the filing stated.

08:14 EST Hologic to showcase portfolio of breast, skeletal health solutions at RSNA 2022 - Hologic will exhibit its portfolio of breast and skeletal health products at the 108th Scientific Assembly and Annual Meeting of the Radiological Society of North America, RSNA, from Nov. 27 to Dec. 1. Among the full suite of breast biopsy and surgery solutions will be Hologic's Affirm Contrast Biopsy software, which will be on display for the first time since becoming commercially available in the United States. "As the global leader in breast imaging, we are committed to addressing the unmet needs of physicians and their patients across the continuum of breast care and we're eager to engage with industry leaders at this year's RSNA meeting to share our vision for the future of breast health," said Erik Anderson, President of Hologic's Breast and Skeletal Health Solutions Division. "We are equally excited to showcase our new Affirm Contrast Biopsy technology, which is a great example of our commitment to physicians and patients in action."

08:03 EST KB Home announces opening of two new communities in California - KB Home announced the grand opening of two new communities within the homebuilder's Nuevo Meadows master plan in the popular Riverside County town of Nuevo. Brisa and Cielo at Nuevo Meadows are situated at Nuevo Road and Lakeview Avenue near Highway 74, Interstate 215 and the Metrolink rail service.

08:01 EST Target announces Cyber Monday sales event from Nov. 27-28 - Target unveiled plans for its two-day Cyber Monday sales event from Nov. 27-28 featuring deep savings on hundreds of thousands of items. The sale includes everything from TVs and laptops to apparel and toys, exclusively on Target.com and the Target app. In addition, guests can expect new deals each week in-store and online throughout December, offering continued value for the entire holiday season

07:32 EST SunOpta announces Kempf to resign from board of directors - SunOpta announced that Ken Kempf, a senior analyst at Engaged Capital has informed SunOpta that he will resign from SunOpta's Board of Directors, effective December 30, 2022, to focus on other business investments. Kempf joined the Board in June 2020 and has provided insight and assistance to the Company and its Board. Kempf also served as a member of the Audit Committee and the Compensation Committee.

06:02 EST Spectrum receives CRL from FDA regarding NDA for poziotinib - Spectrum Pharmaceuticals announced that the company has received a Complete Response Letter from the U.S. FDA regarding Spectrum's New Drug Application for poziotinib for the treatment of patients with previously treated locally advanced or metastatic non-small cell lung cancer harboring HER2 exon 20 insertion mutations. The FDA issued a CRL indicating the poziotinib application cannot be approved in its present form. Based on the CRL, the Company would have to generate additional data including a randomized controlled study prior to approval. "While we are not surprised by the CRL given the ODAC recommendation in September, we are disappointed. After multiple interactions with the FDA since ODAC, and following careful consideration, we have made the strategic decision to immediately de-prioritize the poziotinib program," said Tom Riga, President and CEO of Spectrum Pharmaceuticals. "We continue to believe that poziotinib could present a meaningful treatment option for patients with this rare form of lung cancer, for whom other therapies have failed." The company will de-prioritize poziotinib program activities, effective immediately, and is in the process of reducing its R&D workforce by approximately 75%. Based on the anticipated cost savings from the restructuring, Spectrum believes it will be able to generate the working capital required to support its strategic refocusing through 2024.